Investor · Medfield, MA

Bram Vanparys

Open Bram in the network graph →

Filings

8

SEC Form D

Connections

47

co-filers

Capital

$57.0M

across filings

Active

Aug 2021

to Jul 2023

Most-connected co-filers (47)

Jamil Beg · Medfield, MA5 shared Roger Heerman · Medfield, MA5 shared Robert Clarke · Lexington, MA5 shared Tom King · Medfield, MA5 shared Frazer Morgan · Medfield, MA3 shared David W. Lobe · Washington, Washington, D.C.3 shared Kevin Bitterman · Cambridge, MA3 shared Norma W. Kuntz · Washington, Washington, D.C.3 shared John N. Bishop · St. Peter Port, Y73 shared Jeremy W. Anderson · Washington, Washington, D.C.3 shared Christina W. Gibbs · Washington, Washington, D.C.3 shared Cory B. Sutphin · Albuquerque, NM3 shared Karen W. Mcmonagle · New York, NY3 shared Killian J. Charles · Montreal, Quebec, Canada3 shared Dong Wang · Branford, CT2 shared Austin Sendek · Palo Alto, CA2 shared Venkatasubramanian Viswanathan · Palo Alto, CA2 shared Andre Basbaum · San Diego, CA2 shared Faith Barnett · San Diego, CA2 shared Martha V. Shelley · LOS ANGELES, CA2 shared Jonah J. Lobel · Miami Beach, FL2 shared Digvijay Chauhan · Seattle, WA2 shared Nancy Cho · Seattle, WA2 shared Carlyle Principal Alternative Opportunities Gp, L.P · Washington, Washington, D.C.2 shared

Recent filings (8)

Kinaset Therapeutics, Inc.Jul 2023 · 20 co-filers$41.0M Kinaset Therapeutics, Inc.Jul 2022 · 20 co-filers$41.0M Carlyle Direct Alternative Opportunities Fund II, L.P.Mar 2022 · 12 co-filers Carlyle Principal Alternative Opportunities Fund, L.P.Oct 2021 · 13 co-filers Carlyle Principal Alternative Opportunities Fund, L.P.Sep 2021 · 13 co-filers Lytica Inc.Sep 2021 · 14 co-filers$1.2M Lytica Inc.Aug 2021 · 14 co-filers$850K Kinaset Therapeutics, Inc.Aug 2020 · 13 co-filers$40.0M Kinaset Therapeutics, Inc.Aug 2020 · 13 co-filers$40.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Bram in the interactive graph →